| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/10/2009 | US20090227000 Chimeric adenoviruses for use in cancer treatment |
| 09/10/2009 | US20090226489 Viral vaccine composition, process and methods of use |
| 09/10/2009 | US20090226488 Vaccine comprising an attenuated pestivirus |
| 09/10/2009 | US20090226487 Avian embryo particulate biomass for the production of virus antigens |
| 09/10/2009 | US20090226486 N protein mutants of porcine reproductive and respiratory syndrome virus |
| 09/10/2009 | US20090226442 RON antibodies and uses thereof |
| 09/09/2009 | EP2097517A2 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 09/09/2009 | EP2097516A2 Method for preparing bacteriophages modified by the insertion of random sequences in the screening proteins of said bacteriophages |
| 09/09/2009 | EP1290027B1 Immunoadhesin for the prevention of rhinovirus infection |
| 09/09/2009 | CN101528916A Scalable production method for AAV |
| 09/09/2009 | CN101525597A New hepatitis A inactivated vaccine virus strain and method for culturing same |
| 09/09/2009 | CN100537773C Modified vaccinia ankara virus variant |
| 09/09/2009 | CN100537753C Nephrotropic avian infectious bronchitis HN99 strain virus |
| 09/08/2009 | US7585667 Noncytopathic negative strand; synthetic respiratory syncytial virus (RSV) replicon; Noncytotoxic |
| 09/08/2009 | US7585657 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells; hemagglutinin (HA) and neuraminidase (NA). |
| 09/08/2009 | US7585641 Using colored polystyrene latex particles in diagnostic assay for detecting, lipopolysaccharide, extracellular polysaccharide and/or viral particles and microorganism associated with biosynthesis of matrix biopolymers; drug screening |
| 09/08/2009 | CA2396344C Polymer blends as biodegradable matrices for preparing biocomposites |
| 09/08/2009 | CA2265505C An immune disease remedy, treatment method and preventive agent and method for dogs and cats |
| 09/03/2009 | WO2009106629A1 Viral inactivation process |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221505 Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display |
| 09/03/2009 | US20090220940 Method for Testing the Integrity of Membranes |
| 09/03/2009 | US20090220537 Vaccine delivery system |
| 09/03/2009 | US20090220535 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection |
| 09/03/2009 | US20090220460 Virus strains |
| 09/03/2009 | CA2716593A1 Viral inactivation process |
| 09/02/2009 | EP1373536B9 Lentiviral packaging constructs |
| 09/02/2009 | CN101519657A Full-length infectious cDNA clones of tick borne flavivirus |
| 09/02/2009 | CN101519651A Shigella flexneri phage strain and application thereof |
| 09/02/2009 | CN100535108C Immunizing fish against viral infection |
| 09/02/2009 | CN100534529C Ordered molecular presentation of antigens, method of preparation and use |
| 09/01/2009 | US7582614 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| 09/01/2009 | US7582476 For diagnosis and treatment of estrogenic disorder of mutant ER alpha |
| 09/01/2009 | US7582447 Sodium transport protein for use in identifying modulator for treatment of male infertility |
| 09/01/2009 | US7582303 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand |
| 09/01/2009 | US7582291 A polypeptide of a bacteriophage lysin with a specific amino acid sequence; killing activity against enterococcal bacteria including both E. faecalis/faecium (including vancomycin resistant strains); bactericides; antibiotic resistance; nosocomial infections; rapid detection; grampositive bacteria |
| 09/01/2009 | US7582290 Use in suicide gene therapy of cancer cells and producing immunotoxins; infecting the cell with an adenovirus produced by a packaging cell line, where an adenoviral vector of a promoter is linked to a nucleic acid encoding the A subunit of diphtheria toxin A or Pseudomonas Exotoxin A, mutated EF-2 gene |
| 09/01/2009 | US7582289 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 09/01/2009 | CA2213343C Chimeric adenoviral fiber protein and methods of using same |
| 08/27/2009 | WO2009105152A2 Virus-like particles as vaccines for paramyxovirus |
| 08/27/2009 | WO2009105084A2 Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
| 08/27/2009 | WO2009104964A1 Optimisation of expression of parvoviral rep and cap proteins in insect cells |
| 08/27/2009 | WO2009103752A1 Protein nanocarriers, process for obtaining them and applications |
| 08/27/2009 | WO2009076778A8 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 08/27/2009 | WO2008141151A3 Synthetic herpes simplex viruses type-1 for treatment of cancers |
| 08/27/2009 | US20090215871 Simian adenovirus vectors and methods of use |
| 08/27/2009 | US20090215870 Compositions and methods for targeting of viral vectors |
| 08/27/2009 | US20090215154 Method of preparing micro-and nanometric particles with labile Products |
| 08/27/2009 | US20090215148 bioconjugates of chemically reactive carbocyanine dyes that are intramolecularly crosslinked between the 1-position and the 3-position; use in analysis and separation of molecules and cells and for the detection and quantification of other materials |
| 08/27/2009 | US20090215147 Use of Mutant Herpes Simplex Virus-2 for Cancer Therapy |
| 08/27/2009 | US20090215146 Method for Producing Virus-Type Particles Containing an Active Substance |
| 08/27/2009 | US20090215123 Method for Producing Continuous Cell Lines |
| 08/27/2009 | US20090214590 Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof |
| 08/27/2009 | US20090214587 Recombinant virus and use thereof |
| 08/27/2009 | US20090214479 Attenuated reovirus |
| 08/27/2009 | US20090214429 Methods and compositions related to targeting tumors and wounds |
| 08/27/2009 | CA2715924A1 Optimisation of expression of parvoviral rep and cap proteins in insect cells |
| 08/27/2009 | CA2707029A1 Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
| 08/26/2009 | EP2093287A1 Igg-binding peptide |
| 08/26/2009 | EP2093281A1 Protein nanocarriers, process for obtaining them and applications |
| 08/26/2009 | EP2091962A2 Cells and methodology to generate non-segmented negative-strand rna viruses |
| 08/26/2009 | EP1648481B1 Viral vectors |
| 08/26/2009 | CN101517079A Non-replicating paramyxoviridae virus vector |
| 08/26/2009 | CN101516395A A vaccine for chikungunya virus infection |
| 08/26/2009 | CN101514334A Chicken infectivity bronchitis virus attenuated vaccine strain and application thereof |
| 08/26/2009 | CN100532559C Virus envelope vector for gene transfer |
| 08/26/2009 | CN100532545C A method for producing recombinant viruses using site-specific recombination |
| 08/25/2009 | US7579181 Purification of adenovirus and AAV |
| 08/25/2009 | US7579142 Methods for purification of bacterial cells and components |
| 08/25/2009 | US7579007 Production of “biological carriers” for induction of immune responses and inhibition of viral replication |
| 08/20/2009 | WO2009100521A1 Methods using ion exchange and gel filtration chromatography for poxvirus purification |
| 08/20/2009 | WO2009073104A3 Simian e adenoviruses sadv-39, -25. 2, -26, -30, -37, and -38 |
| 08/20/2009 | WO2008089094A9 Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus |
| 08/20/2009 | US20090209583 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 08/20/2009 | US20090209037 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/20/2009 | US20090208995 Pro-clotting enzyme, and method for detection of endotoxin or (1-3)-beta-d-glucan using the same |
| 08/20/2009 | US20090208924 Generation of Replication Competent Viruses for Therapeutic Use |
| 08/20/2009 | US20090208532 Methods Of Producing Influenza Vaccine Compositions |
| 08/20/2009 | US20090208528 Empty capsids (vlps(-vp4)) of the infectious bursal disease virus (ibdv), obtainment process and applications |
| 08/20/2009 | US20090208527 Multi plasmid system for the production of influenza virus |
| 08/20/2009 | US20090208460 Mutant Herpes Simplex Viruses Comprising Nucleic Acid Encoding A Nitroreductase |
| 08/20/2009 | CA2713891A1 Methods using ion exchange and gel filtration chromatography for poxvirus purification |
| 08/19/2009 | EP2090582A2 Binding molecules for human factor VIII and factor VIII-like proteins |
| 08/19/2009 | EP2089515A2 Respiratory syncytial virus-virus like particle (vlps) |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP0942987B1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 08/19/2009 | CN101511995A Methods and compositions for detecting BK virus |
| 08/19/2009 | CN101511994A Protein production using eukaryotic cell lines |
| 08/19/2009 | CN101508979A Recombinant adenovirus carrying human lactoferrin, preparation and uses thereof |
| 08/19/2009 | CN101508978A Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof |
| 08/19/2009 | CN101508977A Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof |
| 08/19/2009 | CN100529065C A recombinant virus comprising BPI gene and a pharmaceutical composition containing the same and uses thereof |
| 08/19/2009 | CN100529064C Method for reforming high-virulent nuclear polyhedrosis virus of lepidoptera pest |
| 08/19/2009 | CN100528228C Escape mutants of newcastle disease virus as marker vaccines |
| 08/19/2009 | CN100528226C Virus-like particles of human papillomavirus |
| 08/18/2009 | US7575924 Expression vector for use in the treatment and prevention of cancer |
| 08/18/2009 | US7575919 Recombinant vector; overexpresses an adenovirus death protein (ADP), is replication-restricted to neoplastic cells expressing telomerase |
| 08/18/2009 | US7575918 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells |
| 08/18/2009 | US7575752 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 08/18/2009 | CA2223691C Tumor- or cell-specific herpes simplex virus replication |